Edward Chia‐Cheng Lai
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 9
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 11
- Family Practice top 5%
-
- Diabetes Treatment and Management 19
- Ophthalmology top 2%
- Retinal Diseases and Treatments 14
-
- Blood Pressure and Hypertension Studies 12
-
- Schizophrenia research and treatment 10
-
- Acute Ischemic Stroke Management 8
-
- Statistical Methods in Clinical Trials 7
- Co-authors
- Yea‐Huei Kao YangShih‐Chieh ShaoSwu‐Jane LinCheng‐Yang HsiehSheng‐Feng SungChien‐Chou SuMing‐Jui HungChi‐Chun Lai
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (5 papers)
- Partner nations
- TaiwanUnited StatesHong Kong
In The Last Decade
Edward Chia‐Cheng Lai
145 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Toxicology 168
- Geriatrics and Gerontology 170
- Family Practice 71
- Endocrinology, Diabetes and Metabolism 514
- Ophthalmology 230
Countries citing papers authored by Edward Chia‐Cheng Lai
This map shows the geographic impact of Edward Chia‐Cheng Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Chia‐Cheng Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Chia‐Cheng Lai more than expected).
Fields of papers citing papers by Edward Chia‐Cheng Lai
This network shows the impact of papers produced by Edward Chia‐Cheng Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Chia‐Cheng Lai. The network helps show where Edward Chia‐Cheng Lai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Chia‐Cheng Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 29 | |
| 15 | Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database | 2022 | 15 |
| 16 | 2021 | 10 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 33 | |
| 20 | Utility of PROSE in thyroid eye disease patients with recurrent proptosis after orbital decompression | 2019 | 1 |
About Edward Chia‐Cheng Lai
Edward Chia‐Cheng Lai is a scholar working on Toxicology, Geriatrics and Gerontology and Ophthalmology, having authored 162 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (19 papers), Retinal Diseases and Treatments (14 papers), Blood Pressure and Hypertension Studies (12 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Schizophrenia research and treatment (10 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers), Acute Ischemic Stroke Management (8 papers) and Statistical Methods in Clinical Trials (7 papers). The work is most often cited by research in Toxicology (168 citations), Geriatrics and Gerontology (170 citations) and Family Practice (71 citations). Edward Chia‐Cheng Lai has collaborated with scholars based in Taiwan, United States and Hong Kong. Frequent co-authors include Yea‐Huei Kao Yang, Shih‐Chieh Shao, Swu‐Jane Lin, Cheng‐Yang Hsieh, Sheng‐Feng Sung, Chien‐Chou Su, Ming‐Jui Hung, Chi‐Chun Lai, Rong‐Nan Chien and Yuk‐Ying Chan. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.